239 related articles for article (PubMed ID: 30817318)
1. Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Fernandes RC; Hickey TE; Tilley WD; Selth LA
Endocr Relat Cancer; 2019 May; 26(5):R237-R257. PubMed ID: 30817318
[TBL] [Abstract][Full Text] [Related]
2. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
[TBL] [Abstract][Full Text] [Related]
4. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
Chen W; Yao G; Zhou K
J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and miR-206 regulation in prostate cancer.
Chua FY; Adams BD
Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
[TBL] [Abstract][Full Text] [Related]
6. Androgen Signaling in Prostate Cancer.
Dai C; Heemers H; Sharifi N
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 28389515
[TBL] [Abstract][Full Text] [Related]
7. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
Zheng L; Kang Y; Zhang L; Zou W
Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
[TBL] [Abstract][Full Text] [Related]
8. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
Sikand K; Slaibi JE; Singh R; Slane SD; Shukla GC
Int J Cancer; 2011 Aug; 129(4):810-9. PubMed ID: 21710544
[TBL] [Abstract][Full Text] [Related]
9. [The mechanisms of prostate cancer progression through androgen receptor].
Goto Y; Sakamoto S; Ichikawa T
Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations during progression of prostate cancer to androgen independence.
Saraon P; Jarvi K; Diamandis EP
Clin Chem; 2011 Oct; 57(10):1366-75. PubMed ID: 21956922
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
Ebron JS; Shukla GC
Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
14. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer.
Ganapathy K; Staklinski S; Hasan MF; Ottman R; Andl T; Berglund AE; Park JY; Chakrabarti R
Sci Rep; 2020 Mar; 10(1):5167. PubMed ID: 32198489
[TBL] [Abstract][Full Text] [Related]
16. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.
Burnstein KL
J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior.
Leite KR; Morais DR; Florez MG; Reis ST; Iscaife A; Viana N; Moura CM; Silva IA; Katz BS; Pontes J; Nesrallah A; Srougi M
Urol Oncol; 2015 Jun; 33(6):267.e15-22. PubMed ID: 25920548
[TBL] [Abstract][Full Text] [Related]
18. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
19. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review).
Contreras HR; López-Moncada F; Castellón EA
Int J Oncol; 2020 May; 56(5):1075-1082. PubMed ID: 32319606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
